Список литературы :
1. Liu L, Oza S, Hogan D et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: An updated systematic analysis. Lancet 2015; 385: 430-40.
2. Troeger C, Blacker BF, Khalil IA et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect. Dis. 2018; 18: 1211-28.
3. Schnadower D, Finkelstein Y, Freedman SB. Ondansetron and probiotics in the management of pediatric acute gastroenteritis in developed countries. Curr. Opin. Gastroenterol. 2015; 31: 1-6.
4. Dey A, Wang H, Menzies R, Macartney K. Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program. Med. J. Aust. 2012; 197: 453-7.
5. Pendleton A, Galic M, Clarke C et al. Impact of rotavirus vaccination in Australian children below 5 years of age: A database study. Hum. Vaccin. Immunother. 2013; 9: 1617-25.
6. Troeger C, Colombara D, Rao P. Global disability-adjusted life-year estimates of long-term health burden and undernutrition attributable to diarrhoeal diseases in children younger than 5 years. Lancet Glob. Health 2018; 6: e255-69.
7. Lemoh JN, Brooke OG. Frequency and weight of normal stools in infancy. Arch. Dis. Child. 1979; 54: 719-20.
8. Myo-Khin T-W-N, Kyaw-Hla S, Thein-Thein-Myint BTD. A prospective study on defecation frequency, stool weight, and consistency. Arch. Dis. Child. 1994; 71: 311-3.
9. World Health Organization. Diarrhoeal Disease Fact Sheet N 330. [updated 2 May 2017]. Available from: http://www.who.int/ mediacentre/factsheets/fs330/en/ [accessed 29 July 2019].
10. World Health Organization. The Treatment of Diarrhoea. A Manual for Physicians and Other Senior Health Workers. Geneva: The Organization; 2005.
11. Guarino A, Ashkenazi S, Gendrel D, Lo Vecchio A, Shamir R, Szajewska H. European Society for Pediatric Gastroenterology, hepatology, and nutrition; European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: Update 2014. J. Pediatr. Gastroenterol. Nutr. 2014; 59: 132-52.
12. Moore SR, Lima NL, Soares AM et al. Prolonged episodes of acute diarrhoea reduce growth and increase risk of persistent diarrhoea in children. Gastroenterology 2010; 139: 1156-64.
13. Bhutta ZA, Ghishan F, Lindley K et al. Persistent and chronic diarrhea and malabsorption: Working group report of the second world congress of pediatric gastroenterology, hepatology, and nutrition. J. Pediatr. Gastroenterol. Nutr. 2004 Jun; 39 (Suppl. 2): S711-6.
14. Fine KD, Schiller L. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology 1999; 116: 1464-86.
15. Thiagarajah JR, Kamin DS, Acra S et al. Advances in evaluation of chronic diarrhea in infants. Gastroenterology 2018; 154: 2045-2059.e6.
16. Camilleri M. Chronic diarrhea: A review on pathophysiology and management for the clinical gastroenterologist. Clin. Gastroenterol. Hepatol. 2004; 2: 198-206.
17. Kiela PR, Ghishan FK. Physiology of intestinal absorption and secretion. Best Pract. Res. Clin. Gastroenterol. 2016; 30: 145-59.
18. Schiller LR. Definitions, pathophysiology, and evaluation of chronic diarrhoea. Best Pract. Res. Clin. Gastroenterol. 2012; 26: 551-62.
19. Camilleri M, Sellin JH, Barrett KE. Pathophysiology, evaluation, and management of chronic watery diarrhea. Gastroenterology 2017; 152: 515-532.e2.
20. Rao MC, Sarathy J, Sellin JH. Intestinal electrolyte absorption and secretion. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 10th edn. New York, NY: Saunders; 2016; 1713-34.
21. Kaiser L, Surawicz CM. Infectious causes of chronic diarrhoea. Best Pract. Res. Clin. Gastroenterol. 2012; 26: 563-71.
22. Schiller LR, Sellin JH. Diarrhoea. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 10th edn. New York, NY: Saunders; 2016; 221-40.
23. Castro-Rodriguez JA, Salazar-Lindo E, Leôn-Barûa R. Differentiation of osmotic and secretory diarrhoea by stool carbohydrate and osmolar gap measurements. Arch. Dis. Child. 1997; 77: 201-5.
24. Berni Canani R, Pezzella V, Amoroso A, Cozzolino T, Di Scala C, Passariello A. Diagnosing and treating intolerance to carbohydrates in children. Nutrients 2016; 8: 157.
25. Thiagarajah JR, Donowitz M, Verkman AS. Secretory diarrhoea: Mechanisms and emerging therapies. Nat. Rev. Gastroenterol. Hepatol. 2015; 12: 446-57.
26. Schutze GE, Willoughby RE, Committee on Infectious Diseases; American Academy of Pediatrics, et al. Clostridium difficile infection in infants and children. Pediatrics 2013; 131: 196-200.
27. Kim J, Shaklee JF, Smathers S. Risk factors and outcomes associated with severe Clostridium difficile infection in children. Pediatr Infect Dis J. 2012; 31(2): 134-138.
28. Freeman K, Willis BH, Fraser H, Taylor-Phillips S, Clarke A. Faecal calprotectin to detect inflammatory bowel disease: a systematic review and exploratory meta-analysis of test accuracy. BMJ Open. 2019; 9(2): e027428. http://dx.doi.org/10.1136/bmjopen-2018-027428.
29. Garg M, Leach ST, Coffey MJ, et al. Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy children. Journal of Cystic Fibrosis. 2017; 16(5): 631-636. http://dx.doi.org/10.1016/j.jcf.2017.03.010.
30. Greenwald DA. Protein losing enteropathy. In: Feldman M, Friedman LS, Brandt LJ, Ed. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 10th Ed. New York: Saunders. 2016; pp. 464-470.
31. Guarino A, Lo Vecchio A, Berni Canani R. Chronic diarrhoea in children. Best Practice & Research Clinical Gastroenterology. 2012; 26(5): 649-661. http://dx.doi.org/10.1016/j.bpg.2012.11.004.
32. Lindquist S, Hernell O. Lipid digestion and absorption in early life: an update. Current Opinion in Clinical Nutrition and Metabolic Care. 2010; 13(3): 314-320. http://dx.doi.org/10.1097/mco.0b013e32833 7bbf0.
33. Husby S, Murray JA, Katzka DA. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease—Changing Utility of Serology and Histologic Measures: Expert Review. Gastroenterology. 2019; 156 (4): 885-889. http://dx.doi.org/10.1053/j.gastro.2018.12.010.
34. Gould MJ, Brill H, Marcon MA, Munn NJ, Walsh CM. In Screening for Celiac Disease, Deamidated Gliadin Rarely Predicts Disease When Tissue Transglutaminase Is Normal. Journal of Pediatric Gastroenterology and Nutrition. 2019; 68(1): 20-25. http://dx.doi.org/10.1097/mpg. 0000000000002109.
35. Högenauer C, Hammer HF. Maldigestion and malabsorption. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 10th edn. New York, NY: Saunders; 2016; 1788-823.
36. Azer SA, Sankararaman S. Steatorrhea [Updated 4 June 2019]. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK541055/ [Accessed on 29 July 2019]
37. Avelar Rodriguez D, Ryan PM, Toro Monjaraz EM, Ramirez Mayans JA, Quigley EM. Small intestinal bacterial overgrowth in children: A state- of-the-art review. Front. Pediatr. 2019; 7: 363.
38. Sieczkowska A, Landowski P, Zagozdzon P, Kaminska B, Lifschitz C. The association of proton pump inhibitor therapy and small bowel bacterial overgrowth in children. Eur. J. Gastroenterol. Hepatol. 2017; 29: 1190-1.
39. Deloose E, Janssen P, Depoortere I, Tack J. The migrating motor complex: Control mechanisms and its role in health and disease. Nat. Rev. Gastroenterol. Hepatol. 2012; 9: 271-85.
40. Bohm M, Siwiec RM, Wo JM. Diagnosis and management of small intestinal bacterial overgrowth. Nutr. Clin. Pract. 2013; 28: 289-99.
41. Saad RJ, Chey WD. Breath testing for small intestinal bacterial overgrowth: Maximizing test accuracy. Clin. Gastroenterol. Hepatol. 2014; 12: 1964-72.
42. Rezaie A, Buresi M, Lembo A et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: The North American consensus. Am. J. Gastroenterol. 2017; 112: 775-84.
43. Benninga MA, Faure C, Hyman PE, James Roberts I, Schechter NL, Nurko S. Childhood functional gastrointestinal disorders: Neonate/toddler. Gastroenterology 2016; 150: 1443-1455.e2.
44. Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional disorders: Children and adolescents. Gastroenterology 2016; 150: 1456-68.
45. Korterink JJ, Benninga MA, Van Wering HM, Deckers-Kocken JM. Glucose hydrogen breath test for small intestinal bacterial overgrowth in children with abdominal pain-related functional gastrointestinal disorders. J. Pediatr. Gastroenterol. Nutr. 2015; 60: 498-502.
46. Scarpellini E, Giorgio V, Gabrielli M et al. Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome. Eur. Rev. Med. Pharmacol. Sci. 2013; 17: 1314-20.
47. Rodino-Janeiro BK, Vicario M, Alonso-Cotoner C, Pascua-Garcia R, Santos J. A review of microbiota and irritable bowel syndrome: Future in therapies. Adv. Ther. 2018; 35: 289-310.
48. Koletzko S, Niggemann B, Arato A et al. Diagnostic approach and management of cow's-milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines. J. Pediatr. Gastroenterol. Nutr. 2012; 55: 221-9.
49. Prasad D, Srivastava A, Tambe A, Yachha SK, Sarma MS, Poddar U. Clinical profile, response to therapy, and outcome of children with primary intestinal lymphangiectasia. Dig. Dis. 2019 Apr; 26: 1-9.
50. Heikenen JB, Pohl JF, Werlin SL, Bucuvalas JC. Octreotide in pediatric patients. J. Pediatr. Gastroenterol. Nutr. 2002; 35: 600-9.
51. Szilagyi A, Shrier I. Systematic review: The use of somatostatin or octreotide in refractory diarrhoea. Aliment. Pharmacol. Ther. 2001; 15: 1889-97.
52. Guarner F, Khan AG, Garisch J et al. World Gastroenterology Organisation global guidelines: Probiotics and prebiotics October 2011. J. Clin. Gastroenterol. 2012; 46: 468-81.
53. Tack J. Functional diarrhea. Gastroenterol. Clin. North Am. 2012; 41: 629-37.
54. Camilleri M. Bile acid diarrhea: Prevalence, pathogenesis and therapy. Gut Liver 2015; 9: 332-9.
55. Salazar-Lindo E, Santisteban-Ponce J, Chea-Woo E, Gutierrez M. Racecadotril in the treatment of acute watery diarrhea in children. N. Engl. J. Med. 2000; 343: 463-7.
56. Kutak-Bejda A, Bejda G, Waszkiewicz N. Antidepressants for irritable bowel syndrome - A systematic review. Pharmacol. Rep. 2017; 69: 1366-79.
57. Axelrod CH, Saps M. The role of fiber in the treatment of functional gastrointestinal disorders in children. Nutrients 2018; 10: E1650.
58. Rawal N, Yazigi N. Intestinal transplant in children. Pediatr. Clin. North Am. 2017; 64: 613-9.